[Necrotic lesion in a patient with hepatitis C virus liver disease under treatment with pegylated interferon]

Enferm Infecc Microbiol Clin. 2004 Oct;22(8):497-8. doi: 10.1016/s0213-005x(04)73145-6.

[Article in Spanish]

Authors

Luis Rosel¹, José R Blanco, Luis Metota, José Antonio Oteo

Affiliation

¹ Servicio de Enfermedades Infecciosas, Complejo Hospitalario San Millán-San Pedro-La Rioja, Logroño, Spain.

PMID: 15482692
DOI: 10.1016/s0213-005x(04)73145-6

No abstract available

Publication types

Case Reports

MeSH terms

Antiviral Agents / administration & dosage
Antiviral Agents / adverse effects*
Antiviral Agents / therapeutic use
Drug Eruptions / etiology*
Drug Eruptions / pathology
Drug Therapy, Combination
Hepatitis C, Chronic / complications*
Hepatitis C, Chronic / drug therapy
Humans
Injections, Subcutaneous / adverse effects
Interferon alpha-2
Interferon-alpha / administration & dosage
Interferon-alpha / adverse effects*
Interferon-alpha / therapeutic use
Male
Middle Aged
Necrosis
Polyethylene Glycols
Recombinant Proteins
Ribavirin / therapeutic use

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols
Ribavirin
peginterferon alfa-2b